Microcarrier Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017-2021 and Forecast 2022-2028

$ PRICE - $ 3,000.00$ 8,900.00

Microcarrier Market: By Product (Equipment, Consumables, and Microcarrier Beads), By Application (Vaccine Manufacturing, Cell Therapy, and Others), By End User (Pharmaceutical & Biotechnology Companies, Research Institutes, and Contract Research Organizations), and Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Categories: ,

Report

Description

Microcarrier Market was valued at USD 1.9 billion in 2021, growing at a significant CAGR of 11.6% during the forecast period 2022-28. The increasing demand for cell-based vaccines and mammalian cells in the biopharmaceutical industry and research institutes, and availability of private and public funding on cell-based research and advancements in technology drives the growth of the market. However, high cost of cell biology research and limitations in the production density hinders the growth of the market over the forecasted period. Following the World Health Organization’s (WHO) declaration of the epidemic as a pandemic, a combination of big pharmaceutical corporations and small start-ups rushed to create treatments and vaccinations. Companies have increased their research and development efforts in order to create vaccinations and treatments to combat the virus. Vaccine-related research in pharmaceutical and biotechnological firms, research centres, and academic and research institutes is regarded critical, and operations and output have been largely unaffected. Both the availability of financing and the demand for cell culture supplies, particularly microcarrier products, are likely to expand as research scales up.

Microcarrier Market

MARKET SUMMARY
-
11.6%
  • Study Period– 2022-2028
  • Base Year– 2021
  • CAGR– 11.6%
  • Largest Market– Europe
  • Fastest Growing Market– Asia Pacific

Microcarrier Market

  • The report on global Microcarrier Market gives historical, current, and future market sizes (US$ Bn) on the basis of product, application, end user and geography.
  • Microcarrier Market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • Key stakeholders of the global market report include suppliers, manufacturers, marketers, policy makers, and healthcare service providers engaged in global microcarrier products.
Key Players
  • Thermo Fisher Scientific
  • GE Healthcare (A Subsidiary of General Electric Company)
  • Corning
  • Sartorius AG
  • Danaher Corporation
Microcarrier Market Dynamics

Increase in demand for consumables and continuous consumption of various media and reagents for various culture process and applications fuels the growth of the market over the forecasted period. Pharmaceutical and biopharmaceutical companies has registered highest market share among all the end users in the market and is forecasted to grow at a significant CAGR over the forecasted years.


Europe Got Significant Share

Microcarrier Market

Europe accounted for larger revenue share in global microcarrier market with significant CAGR owing to presence of large number of market players in the market and increasing prevalence of cancer and rising number of venture capital investments and availability of technologically advanced products drives the growth of the market. North America and Asia Pacific expected to be the faster growing region in market over the forecast period.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Key Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market (2017-2021) and forecast (2022-2028)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Microcarrier Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.


Report

Table Of Content


Report

Company Profile

  • Thermo Fisher Scientific
  • GE Healthcare (A Subsidiary of General Electric Company)
  • Corning
  • Sartorius AG
  • Danaher Corporation
  • Merck KGaA
  • Becton, Dickinson and Company
  • Eppendorf
  • Hi-Media Laboratories
  • Lonza Group AG

Description

Microcarrier Market was valued at USD 1.9 billion in 2021, growing at a significant CAGR of 11.6% during the forecast period 2022-28. The increasing demand for cell-based vaccines and mammalian cells in the biopharmaceutical industry and research institutes, and availability of private and public funding on cell-based research and advancements in technology drives the growth of the market. However, high cost of cell biology research and limitations in the production density hinders the growth of the market over the forecasted period. Following the World Health Organization’s (WHO) declaration of the epidemic as a pandemic, a combination of big pharmaceutical corporations and small start-ups rushed to create treatments and vaccinations. Companies have increased their research and development efforts in order to create vaccinations and treatments to combat the virus. Vaccine-related research in pharmaceutical and biotechnological firms, research centres, and academic and research institutes is regarded critical, and operations and output have been largely unaffected. Both the availability of financing and the demand for cell culture supplies, particularly microcarrier products, are likely to expand as research scales up.

ASIA PACIFIC OFFICE

Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad - 500072

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX